Among the major functions of a life science company’s pharmacovigilance (PV) department, case management is one of the most resource-intensive processes, involving considerable manual activities. The ‘digital revolution’ that has already transformed other industries, has not yet been truly implemented in the world of pharmacovigilance. Aman Wasan at ArisGlobal explains how these challenges can be effectively tackled by optimising the pharmacovigilance processes using recent technological advances in the field of cognitive computing, such as robotic process automation (RPA), artificial intelligence (AI), and machine learning (ML).

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2018/05/Cognitive-pharmacovigilance….pdf” width=”100%” height=”900px” style=”border:0;”]